The FDA has introduced a new program that promises super-fast drug approvals. This program, called the Commissioner’s National Priority Voucher, can approve drugs in just one to two months. This is much faster than the usual 10-month review process. The idea is to prioritize drugs that match certain
The FDA plans to give money to reviewers who finish ahead of time. Commissioner Makary explained the idea in a staff meeting last week. He called it a pilot program and said the first bonuses could start in August. The goal is to reward “weighted time savings” while keeping quality high. O
A leading health news site has earned a top journalism prize for its coverage of the changes in federal health policy under the last U. S. president. The award highlighted stories that traced how the Food and Drug Administration was reshaped, how scientific research funding shifted, and what these m
A recall has been issued for a specific batch of "Tippy Toes" baby food. The reason? Elevated levels of patulin, a substance produced by molds that can grow on fruits like apples. This recall is a precautionary measure, as long-term exposure to patulin can potentially cause health issues, including
Encora Therapeutics has earned FDA approval for its wrist‑sized device, the Encora X1, which can be prescribed to adults who suffer from essential tremor. The clearance means the product can now be sold in the United States for this specific use. Clinical data from two trials support the decision.
The U. S. Food and Drug Administration has started a fresh examination of butylated hydroxyanisole, a preservative that keeps many packaged foods from spoiling. The agency wants the public to share any new data on how BHA is used and whether it remains safe. This effort follows a 2025 program
The U. S. Food and Drug Administration has decided not to review Moderna’s mRNA flu vaccine, even though the company spent years and millions of dollars on testing. The decision came after the agency’s chief vaccine regulator, Dr. Vinay Prasad, raised a concern. He said the trial used a compar
Coffee lovers, listen up! The FDA has just pulled over 80, 000 Keurig coffee pods off the market. Why? Because these decaf pods might actually have caffeine in them. Yep, you read that right. The McCafe Premium Roast Decaf Coffee K-Cup Pods are the culprits here. These pods were sold in California,
A device approved by the FDA for treating ADHD in children has been found ineffective in a recent clinical trial. The external trigeminal nerve stimulator, which was expected to reduce ADHD symptoms, showed no significant improvement compared to a placebo. The FDA had initially approved the device
Robert F. Kennedy Jr. has made waves recently by pushing for a closer look at cell phone radiation. He managed to get the FDA to remove their long-standing information that said cell phones are safe. This move has sparked a lot of debate, especially since many health groups still say there's no stro
